Insider · CIK 0001363812
Molly Henderson
Files at PHAT (Phathom Pharmaceuticals, Inc.). First filing Dec 20, 2024, latest Apr 8, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PHAT: Phathom Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | PHATsell Phathom Pharmaceuticals, Inc. | $17k 3,678 shares | -4% | +15% from low-75% from high | |
| 36Weak | Phathom Pharmaceuticals, Inc. | $43k 6,583 shares | -7% | - | |
| 30Weak | Phathom Pharmaceuticals, Inc. | $10k 1,291 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | PHAT Phathom Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -3,678 | $4.55 | $17k | 89,868 | Apr 8, 2025 |
| Feb 27, 2025 | PHAT Phathom Pharmaceuticals, Inc. | AGrant or award Common Stock | +72,000 | $0.00 | $0 | 165,546 | Mar 3, 2025 |
| Feb 27, 2025 | PHAT Phathom Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Mar 3, 2025 |
| Jan 21, 2025 | PHAT Phathom Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -6,583 | $6.59 | $43k | 93,546 | Jan 23, 2025 |
| Dec 19, 2024 | PHAT Phathom Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,291 | $8.00 | $10k | 98,156 | Dec 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.